Gea Pharma Systems AG

Gea Pharma Systems AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of GEA Group Aktiengesellschaft, which may influence its climate commitments and reporting practices.

While Gea Pharma Systems AG has not set specific reduction targets or initiatives, it is important to note that it inherits climate commitments from its parent company, GEA Group Aktiengesellschaft. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded down from GEA Group.

As a part of GEA Group, Gea Pharma Systems AG aligns with industry standards for climate action, although specific targets and achievements at the subsidiary level remain unspecified. The company is expected to contribute to the overarching sustainability goals set by its parent organisation, which may include commitments to reduce emissions across all scopes in the future.

In summary, while Gea Pharma Systems AG does not currently report specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate action through its affiliation with GEA Group Aktiengesellschaft.